(149 days)
No
The document describes a software planning tool and patient-specific guides/models based on CT scans and surgeon planning. There is no mention of AI or ML algorithms being used for image processing, planning, or guide design. The process appears to be based on anatomical landmarks and surgeon input.
No
The device is a surgical instrument and planning tool used to assist in the intraoperative positioning of glenoid components during shoulder arthroplasty. It does not directly treat a disease or condition.
No
The descriptions consistently state that the device is a "surgical instrument" or "patient-specific medical device" intended to "assist in the intraoperative positioning of glenoid components" and "transfer the glenoid plan to surgery." It is described as a "planning tool" and a "guide and models" used during surgery, rather than for diagnosing a condition or disease.
No
The device description explicitly states the system is composed of a software component AND patient-specific guides and models, which are physical components.
Based on the provided information, the Materialise Shoulder Guide and Models are not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use clearly states that the device is a "surgical instrument to assist in the intraoperative positioning of glenoid components used with total and reverse shoulder arthroplasty by referencing anatomic landmarks of the shoulder that are identifiable on preoperative CT-imaging scans." This describes a surgical tool used during a procedure, not a device used to examine specimens in vitro (outside the body) to provide diagnostic information.
- Device Description: The description reinforces that it's a "patient-specific medical device that is designed to be used to assist the surgeon in the placement of shoulder components during total anatomic and reverse shoulder replacement surgery." It involves software for planning and physical guides/models for use in the operating room.
- Lack of IVD Characteristics: The description does not mention any analysis of biological samples (blood, tissue, etc.) or the provision of diagnostic information about a patient's health status.
The device is a surgical planning and guidance system, falling under the category of surgical instruments and potentially patient-specific implants/guides, rather than IVDs.
N/A
Intended Use / Indications for Use
Hardware: The Materialise Shoulder Guide and Models are intended to be used as a surgical instrument to assist in the intraoperative positioning of glenoid components used with total and reverse shoulder arthroplasty by referencing anatomic landmarks of the shoulder that are identifiable on preoperative CT-imaging scans. The Materialise Shoulder Guide and Models are single use only. The Materialise Shoulder Guide and Models can be used in conjunction with the following total and reverse shoulder implants systems and their respective compatible components: · Depuy Synthes' o GLOBAL® APG+ Shoulder System (K052472), o DELTA XTEND™ Reverse Shoulder System (K120174, K062250, K183077, K203694) o GLOBAL® STEPTECH® APG Shoulder System (K092122) o Ignite Anatomic Shoulder System (K202716) (rebranded to INHANCE™ Anatomic Shoulder System)) • DJO's o Reverse® Shoulder Prosthesis (K051075, K111629, K092873), o Turon® Shoulder System (K080402) o AltiVate™ Anatomic Shoulder System (K162024) · Smith & Nephew's (Integra's)2 o Titan™ Total Shoulder System (K100448, K112438, K142413, K152047) o Titan™ Reverse Shoulder System (K130050, K161189, K173717, K181999) • Lima's o SMRTM Shoulder System (K100858), o SMRTM Reverse Shoulder System (K110598), o SMR™ Modular Glenoid (K113254) (K143256), - o SMR™ 3-Pegs Glenoid (K130642), o SMR™ TT Metal Back Glenoid (K133349), - o SMRTM 40mm Glenosphere (K142139). · Stryker's o ReUnion RSA Reverse Shoulder System (K183039) o Reunion TSA Total Shoulder Arthroplasty System (K183039). Software: Surgicase Shoulder Planner is intended to be used as a pre-surgical planner for simulation of surgical interventions for shoulder orthopedic surgery. The software is used to assist in the positioning of shoulder components. SurgiCase Shoulder Planner allows the surgeon to visualize, measure, reconstruct, annotate and edit pre-surgical plan data. The software leads to the generation of a surgery report along with a pre-surgical plan data file which can be used as input data to design the Materialise Shoulder Guide and Models.
Product codes (comma separated list FDA assigned to the subject device)
QHE, KWS, PHX
Device Description
Materialise Shoulder System™ is a patient-specific medical device that is designed to be used to assist the surgeon in the placement of shoulder components during total anatomic and reverse shoulder replacement surgery. This can be done by generating a pre-surgical shoulder plan and, if requested by the surgeon, by manufacturing a patient-specific glenoid guide and models to transfer the glenoid plan to surgery. The device is a system composed of the following: - a software component, branded as SurgiCase Shoulder Planner. This software is a planning tool used to generate a pre-surgical plan for a specific patient. - Materialise Shoulder Guide and Models, which are a patient-specific guide and models that are based on a pre-surgical plan. This pre-surgical plan is generated using the software component. Patient-specific glenoid guide and models will be manufactured if the surgeon requests patient-specific guides to transfer the glenoid plan to surgery. The Materialise Shoulder Guide is designed and manufactured to fit the anatomy of a specific patient. A bone model of the scapula is delivered with the Materialise Shoulder Guide. A graft model can be delivered with the Materialise Shoulder Guide. The graft model visualizes the graft-space between implant and bone, based on the pre-operative planning of the surgeon. The graft serves as a visual reference for the surgeon in the OR. The Materialise Shoulder Guide and Models must only be used within the intended use of the compatible components.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
CT-imaging scans.
Anatomical Site
shoulder
Indicated Patient Age Range
Not Found
Intended User / Care Setting
surgeon, OR (Operating Room)
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Hardware: Previous testing for debris and dimensional stability and new testing for biocompatibility, sterility, cleaning and packaging are applicable to the subject device and demonstrate substantial equivalence with the predicate device. Testing verified that the accuracy and performance of the system is adequate to perform as intended. The stability of the device placement, surgical technique, intended use and functional elements of the subject device are the same as that of the predicate Materialise Glenoid Positioning System K193560 and previously cleared devices K190286, K172054, K170893, K153602 and K131559, and therefore previous simulated surgeries using rapid prototyped bone models and previous cadaver testing on previously cleared devices K153602 and K131559 are considered applicable to the subject device.
Biocompatibility re-evaluation according to the new ISO 10993-1:2018 was done.
End-user sterilization re-evaluation using an overkill method partial cycle in accordance with ISO 17665-1:2006 on a new worst case design. All samples passed the sterilization test, validating the applied sterilization parameters for the subject device.
End-user cleaning re-evaluation was done on extended cleaning cycle specifications, including testing of both manual and automated cleaning cycle with both enzymatic and alkaline detergent on a new worst case design. All samples passed the cleaning the updated cleaning parameters.
Packaging: An additional packaging configuration was added to the packaging specifications and testing was performed. The worst-case design test samples representing the subject device passed the packaging and shipment test, validating the new packaging configuration defined in the specifications.
Software: Software verification and validation were performed and documentation was provided following the "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices." This includes verification against defined requirements, and validation against user needs.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3660 Shoulder joint metal/polymer semi-constrained cemented prosthesis.
(a)
Identification. A shoulder joint metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a shoulder joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a humeral resurfacing component made of alloys, such as cobalt-chromium-molybdenum, and a glenoid resurfacing component made of ultra-high molecular weight polyethylene, and is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II. The special controls for this device are:(1) FDA's:
(i) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical Devices—Part I: Evaluation and Testing,’ ”
(ii) “510(k) Sterility Review Guidance of 2/12/90 (K90-1),”
(iii) “Guidance Document for Testing Orthopedic Implants with Modified Metallic Surfaces Apposing Bone or Bone Cement,”
(iv) “Guidance Document for the Preparation of Premarket Notification (510(k)) Application for Orthopedic Devices,” and
(v) “Guidance Document for Testing Non-articulating, ‘Mechanically Locked’ Modular Implant Components,”
(2) International Organization for Standardization's (ISO):
(i) ISO 5832-3:1996 “Implants for Surgery—Metallic Materials—Part 3: Wrought Titanium 6-aluminum 4-vandium Alloy,”
(ii) ISO 5832-4:1996 “Implants for Surgery—Metallic Materials—Part 4: Cobalt-chromium-molybdenum casting alloy,”
(iii) ISO 5832-12:1996 “Implants for Surgery—Metallic Materials—Part 12: Wrought Cobalt-chromium-molybdenum alloy,”
(iv) ISO 5833:1992 “Implants for Surgery—Acrylic Resin Cements,”
(v) ISO 5834-2:1998 “Implants for Surgery—Ultra-high Molecular Weight Polyethylene—Part 2: Moulded Forms,”
(vi) ISO 6018:1987 “Orthopaedic Implants—General Requirements for Marking, Packaging, and Labeling,” and
(vii) ISO 9001:1994 “Quality Systems—Model for Quality Assurance in Design/Development, Production, Installation, and Servicing,” and
(3) American Society for Testing and Materials':
(i) F 75-92 “Specification for Cast Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implant Material,”
(ii) F 648-98 “Specification for Ultra-High-Molecular-Weight Polyethylene Powder and Fabricated Form for Surgical Implants,”
(iii) F 799-96 “Specification for Cobalt-28 Chromium-6 Molybdenum Alloy Forgings for Surgical Implants,”
(iv) F 1044-95 “Test Method for Shear Testing of Porous Metal Coatings,”
(v) F 1108-97 “Specification for Titanium-6 Aluminum-4 Vanadium Alloy Castings for Surgical Implants,”
(vi) F 1147-95 “Test Method for Tension Testing of Porous Metal,”
(vii) F 1378-97 “Standard Specification for Shoulder Prosthesis,” and
(viii) F 1537-94 “Specification for Wrought Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implants.”
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA) along with the Department of Health & Human Services. The FDA logo features a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG" in blue, and "ADMINISTRATION" in a smaller font size below. To the left of the FDA logo is the symbol of the Department of Health & Human Services, which consists of a stylized human figure.
Materialise NV January 12, 2022 Simona Beri Regulatory Affairs Specialist Technologielaan 15 Leuven, 3001 Belgium Re: K212569 Trade/Device Name: Materialise Shoulder System™, Materialise Shoulder Guide and Models, SurgiCase Shoulder Planner Regulation Number: 21 CFR 888.3660 Regulation Name: Shoulder joint metal/polymer semi-constrained cemented prosthesis Regulatory Class: Class II Product Code: QHE, KWS, PHX Dated: December 15, 2021 Received: December 15, 2021
Dear Simona Beri:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
For Jiping Chen, M.D., Ph.D., M.P.H. Acting Division Director DHT6A:Division of Joint Arthroplasty Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K212569
Device Name Materialise Shoulder System™ Materialise Shoulder Guide and Models SurgiCase Shoulder Planner
Indications for Use (Describe)
Hardware
The Materialise Shoulder Guide and Models are intended to be used as a surgical instrument to assist in the intraoperative positioning of glenoid components used with total and reverse shoulder arthroplasty by referencing anatomic landmarks of the shoulder that are identifiable on preoperative CT-imaging scans.
The Materialise Shoulder Guide and Models are single use only.
The Materialise Shoulder Guide and Models can be used in conjunction with the following total and reverse shoulder implants systems and their respective compatible components:
· Depuy Synthes'
o GLOBAL® APG+ Shoulder System (K052472),
o DELTA XTEND™ Reverse Shoulder System (K120174, K062250, K183077, K203694)
o GLOBAL® STEPTECH® APG Shoulder System (K092122)
o Ignite Anatomic Shoulder System (K202716) (rebranded to INHANCE™ Anatomic Shoulder System))
• DJO's
o Reverse® Shoulder Prosthesis (K051075, K111629, K092873),
o Turon® Shoulder System (K080402)
o AltiVate™ Anatomic Shoulder System (K162024)
· Smith & Nephew's (Integra's)2
o Titan™ Total Shoulder System (K100448, K112438, K142413, K152047)
o Titan™ Reverse Shoulder System (K130050, K161189, K173717, K181999)
• Lima's
o SMRTM Shoulder System (K100858),
o SMRTM Reverse Shoulder System (K110598),
o SMR™ Modular Glenoid (K113254) (K143256),
-
o SMR™ 3-Pegs Glenoid (K130642),
o SMR™ TT Metal Back Glenoid (K133349), -
o SMRTM 40mm Glenosphere (K142139).
· Stryker's
o ReUnion RSA Reverse Shoulder System (K183039)
o Reunion TSA Total Shoulder Arthroplasty System (K183039).
Software
Surgicase Shoulder Planner is intended to be used as a pre-surgical planner for simulation of surgical interventions for shoulder orthopedic surgery. The software is used to assist in the positioning of shoulder components. SurgiCase Shoulder Planner allows the surgeon to visualize, measure, reconstruct, annotate and edit pre-surgical plan data. The software leads to the generation of a surgery report along with a pre-surgical plan data file which can be used as input data to design the Materialise Shoulder Guide and Models.
' The implant system was originally cleared under K202716 as the Ignite Anatomic Shoulder System, and was rebranded by Depuy Synthes as INHANCETM Anatomic Shoulder System.
2 Shoulder implants systems and their respective compatible components are branded as Integra, however they were bought by Smith & Nephew in 2020
3
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
510(k) Summary
The following section is included as required by the Safe Medical Devices Act (SMDA) of 1990 and 21CFR 807.92
| Company name | Materialise N.V. |
|---|---|
| Establishment registration number | 3003998208 |
| Street Address | Technologielaan 15 |
| City | Leuven |
| Postal code | 3001 |
| Country | Belgium |
| Phone number | +32 16 74 45 71 |
| Fax number | +32 16 39 66 06 |
| Principal Contact person | Simona Beri |
| Contact title | Regulatory Affairs Specialist |
| Contact e-mail address | REGULATORY.AFFAIRS@MATERIALISE.BE |
| Additional contact person | Nele Daemen |
| Contact title | Technical product manager |
| Contact e-mail address | NELE.DAEMEN@MATERIALISE.BE |
Submission date
The date of the Traditional 510(k) submission is August 13, 2021.
Submission information
| Trade Name | Materialise Shoulder System™
Materialise Shoulder Guide and Models
SurgiCase Shoulder Planner |
|--------------------------|-----------------------------------------------------------------------------------------------------|
| Common Name | Patient specific instrumentation for shoulder arthroplasty + 3D
planning software |
| Classification Name | Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer
Cemented |
| Primary product code | QHE (21 CFR 888.3660) |
| Additional product codes | KWS (21 CFR 888.3660)
PHX (21 CFR 888.3660) |
5
Predicate Device
The predicate device to which substantial equivalence is claimed:
| Trade or proprietary or model name | Materialise Shoulder Guide And Models,
Materialise SurgiCase Shoulder Planner,
Materialise Shoulder Planner,
SurgiCase Shoulder Planner,
SurgiCase Planner |
|------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 510(k) number | K193560 |
| Decision date | March 20, 2020 |
| Classification product code | QHE (21 CFR 888.3660)
KWS (21 CFR 888.3660)
PHX (21 CFR 888.3660) |
| Manufacturer | Materialise N.V. |
Reference Device
| Trade or proprietary or model name | N/A |
|---|---|
| 510(k) number | N/A |
| Decision date | N/A |
| Classification product code | N/A |
| Manufacturer | N/A |
6
Device Description
Materialise Shoulder System™ is a patient-specific medical device that is designed to be used to assist the surgeon in the placement of shoulder components during total anatomic and reverse shoulder replacement surgery. This can be done by generating a pre-surgical shoulder plan and, if requested by the surgeon, by manufacturing a patient-specific glenoid guide and models to transfer the glenoid plan to surgery. The device is a system composed of the following:
- a software component, branded as SurgiCase Shoulder Planner. This software is a planning tool used to generate a pre-surgical plan for a specific patient.
- Materialise Shoulder Guide and Models, which are a patient-specific guide and models that are based on a pre-surgical plan. This pre-surgical plan is generated using the software component. Patient-specific glenoid guide and models will be manufactured if the surgeon requests patient-specific guides to transfer the glenoid plan to surgery. The Materialise Shoulder Guide is designed and manufactured to fit the anatomy of a specific patient. A bone model of the scapula is delivered with the Materialise Shoulder Guide. A graft model can be delivered with the Materialise Shoulder Guide. The graft model visualizes the graft-space between implant and bone, based on the pre-operative planning of the surgeon. The graft serves as a visual reference for the surgeon in the OR.
The Materialise Shoulder Guide and Models must only be used within the intended use of the compatible components.
Indications for Use
Hardware
The Materialise Shoulder Guide and Models are intended to be used as a surgical instrument to assist in the intraoperative positioning of glenoid components used with total and reverse shoulder arthroplasty by referencing anatomic landmarks of the shoulder that are identifiable on preoperative CT-imaging scans.
The Materialise Shoulder Guide and Models are single use only.
The Materialise Shoulder Guide and Models can be used in conjunction with the following total and reverse shoulder implants systems and their respective compatible components:
- Depuy Synthes'
- DJO's ●
4 The implant system was originally cleared under K202716 as the Ignite Anatomic Shoulder System, and was rebranded by Depuy Synthes as INHANCETM Anatomic Shoulder System.
7
- AltiVate™ Anatomic Shoulder System (K162024) O
- Smith & Nephew's (Integra's)2
- . Lima's
- Stryker's
Software
SurgiCase Shoulder Planner is intended to be used as a pre-surgical planner for simulation of surgical interventions for shoulder orthopedic surgery. The software is used to assist in the positioning of shoulder components. SurgiCase Shoulder Planner allows the surgeon to visualize, measure, reconstruct, annotate and edit pre-surgical plan data. The software leads to the generation of a surgery report along with a pre-surgical plan data file which can be used as input data to design the Materialise Shoulder Guide and Models.
Functioning of the Device
The Materialise Shoulder System™ generates a pre-surgical plan based on medical imaging data using the SurgiCase Shoulder Planner. The SurgiCase Shoulder Planner allows a qualified surgeon to visualize, measure, reconstruct, annotate, edit and approve pre-surgical plan data, which leads to the generation of a case planning report. The SurgiCase Shoulder Planner (SCSP) allows for the creation of a glenoid and/or humeral pre-operative plan. If requested by the surgeon, Materialise Shoulder Guide and Models are designed and manufactured based on the approved glenoid pre-surgical plan. Materialise Shoulder Guide and Models are patient specific templates which transfer the pre-operatively determined pin positioning to the patient intraoperatively assisting the surgeon in positioning glenoid components used with total and reverse shoulder arthroplasty procedures. The Materialise Shoulder Guide and Models are available for glenoid components only.
8
Technological Characteristics
The Materialise Shoulder System™ has an equivalent intended use and the same fundamental scientific technology as the predicate device. The subject device's software is intended for positioning shoulder components, i.e. glenoid components and humeral components (same as the predicate device). The subject device's hardware is intended for positioning shoulder glenoid components only (same as the predicate device).
Software
The subject software device employs similar fundamental technologies as the predicate software device. Technological similarities include:
- Device functionality: The planning functionality, visualization options and planning features are exactly the same for the glenoid planning of the subject device as for the predicate device
- Software technology: The subject device has the same code base as the predicate device and uses exactly the same methods for design and verification and validation as the predicate device.
Following technological differences exist between the subject device software and the predicate device software:
- . The main differences between the subject device and previously cleared predicate device K193560 is the addition of the following Depuy Synthes' components in the software component of the subject device for the surgeon to select during the planning stage:
The subject software technology differences have been demonstrated to not affect safety or effectiveness or raise new issues of safety or effectiveness compared to the predicate device.
Hardware
The subject hardware device is substantially equivalent in intended use, design, functionality, operating principles, materials and performance characteristics to the predicate device.
The main difference between the subject device hardware and the predicate device is:
- Extension of compatibility of SurgiCase Shoulder Guides and Models with additional Depuy Synthes' Implant components:
3 The implant system was originally cleared under K202716 as the Ignite Anatomic Shoulder System, and was rebranded by Depuy Synthes as INHANCETM Anatomic Shoulder System.
9
Performance Data (non-clinical)
Hardware:
Previous testing for debris and dimensional stability and new testing for biocompatibility, sterility, cleaning and packaging are applicable to the subject device and demonstrate substantial equivalence with the predicate device. Testing verified that the accuracy and performance of the system is adequate to perform as intended. The stability of the device placement, surgical technique, intended use and functional elements of the subject device are the same as that of the predicate Materialise Glenoid Positioning System K193560 and previously cleared devices K190286, K172054, K170893, K153602 and K131559, and therefore previous simulated surgeries using rapid prototyped bone models and previous cadaver testing on previously cleared devices K153602 and K131559 are considered applicable to the subject device.
Although no additional tests in comparison with the predicate device testing were required to support substantial equivalence, new packaging, biocompatibility, end-user cleaning and sterilization testing has been done for other reasons as explained in section below.
- -Biocompatibility re-evaluation according to the new ISO 10993-1:2018 was done.
- -End-user sterilization re-evaluation using an overkill method partial cycle in accordance with ISO 17665-1:2006 on a new worst case design. (The worst-case design was modified to cover a broader portfolio of Materialise medical devices, including the subject device). All samples passed the sterilization test, validating the applied sterilization parameters for the subject device.
- -End-user cleaning re-evaluation was done on extended cleaning cycle specifications, including testing of both manual and automated cleaning cycle with both enzymatic and alkaline detergent on a new worst case design. (The worst-case design was modified to cover a broader portfolio of Materialise medical devices, including the subject device). All samples passed the cleaning the updated cleaning parameters.
- -Packaging: An additional packaging configuration was added to the packaging specifications and testing was performed. The worst-case design test samples representing the subject device passed the packaging and shipment test, validating the new packaging configuration defined in the specifications.
Software:
Software verification and validation were performed and documentation was provided following the "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices." This includes verification against defined requirements, and validation against user needs.
Conclusion
The non-clinical performance testing indicates that the subject device is as safe, as effective, and performs as well as the predicate device. Therefore it can be concluded that the Materialise Shoulder System™ is substantial equivalent to the predicate device.